Interest and Impact of Skin Cancer Genetic Testing

PERSONALIZED GENOMIC TESTING FOR MELANOMA: MAXIMIZING COMPREHENSION AND HEALTH OUTCOMES IN SKIN CANCER PATIENTS

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02941900

Enrollment

Registered

2016-10-21

Start date

2016-08-31

Completion date

2023-01-18

Last updated

2023-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-melanoma Skin Cancer (NMSC)

Keywords

Genetic Testing, 16-1243

Brief summary

The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing. Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.

Interventions

GENETICMC1R genotyping

BEHAVIORALMC1R Testing Website

The website includes three educational modules about genetic testing with corresponding knowledge questions.

BEHAVIORALBaseline Survey

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years of age or older * English fluent as we do not have the resources to translate all the materials including the website and risk feedback materials into other languages * Prior history of stage 0, I or II NMSC as per EMR or clinical judgment

Exclusion criteria

* Inability to provide meaningful informed consent due to cognitive or psychiatric disability as determined by the judgement of the consenting professional or clinician

Design outcomes

Primary

Measure	Time frame
number of patients interested in MC1R testing	1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026